George Budwell
George Budwell, Ph.D., is a contributing Biotechnology and Technology Analyst at The Motley Fool, covering disruptive innovators in healthcare, defense, and artificial intelligence, and writing on portfolio theory, dividend stocks, and value investing. Prior to The Motley Fool, George was a freelance medical and science writer for various organizations, as well as an independent consultant for multiple life sciences-oriented hedge funds. In a former life, he was an evolutionary biologist, having completed two postdoctoral fellowships at Kyoto University and Illinois State University, respectively. He holds a Ph.D. in Evolutionary Biology from Tulane University and a B.S. (pre-med) from Loyola University. Fun fact: George is an avid golfer, nature enthusiast, and proud father of four.
Recent Articles by George Budwell

2 Cheap Tech Stocks I'm Buying Right Now

2 Value Stocks I'm Buying Right Now

Why Pfizer Is My Largest Healthcare Position

Is Quantum Computing Pioneer IonQ the Next Nvidia?

2 Incredible Growth Stocks I'm Buying Hand Over Fist

2 High-Quality Dividend Stocks to Buy Right Now

3 Essential AI Infrastructure Stocks to Buy Right Now

2 AI Stocks I Can't Stop Buying

3 Dividend Stocks to Buy for Reliable Passive Income

3 Dividend Growth Stocks to Buy Right Now

Is D-Wave Quantum Stock Still a Buy?

2 Space Stocks I'm Buying on the Dip
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.